Publicaciones en las que colabora con Stanisław Sław S. Gõźdź (53)

2021

  1. The histology of brain tumors for 67 331 children and 671 085 adults diagnosed in 60 countries during 2000-2014: a global, population-based study (CONCORD-3)

    Neuro-Oncology, Vol. 23, Núm. 10, pp. 1765-1776

2020

  1. Endocrine treatment and incidence of relapse in women with oestrogen receptor-positive breast cancer in Europe: a population-based study

    Breast Cancer Research and Treatment, Vol. 183, Núm. 2, pp. 439-450

  2. Reasons for low cervical cancer survival in new accession European Union countries: a EUROCARE-5 study

    Archives of Gynecology and Obstetrics, Vol. 301, Núm. 2, pp. 591-602

2019

  1. Epidemiology of rare cancers and inequalities in oncologic outcomes

    European Journal of Surgical Oncology, Vol. 45, Núm. 1, pp. 3-11

  2. Mesothelioma and thymic tumors: Treatment challenges in (outside) a network setting

    European Journal of Surgical Oncology, Vol. 45, Núm. 1, pp. 75-80

  3. Testicular germ-cell tumours and penile squamous cell carcinoma: Appropriate management makes the difference

    European Journal of Surgical Oncology, Vol. 45, Núm. 1, pp. 60-66

  4. Treatment challenges in and outside a network setting: Head and neck cancers

    European Journal of Surgical Oncology, Vol. 45, Núm. 1, pp. 40-45

  5. Treatment challenges in and outside a network setting: Soft tissue sarcomas

    European Journal of Surgical Oncology, Vol. 45, Núm. 1, pp. 31-39

  6. Treatment challenges in and outside a specialist network setting: Pancreatic neuroendocrine tumours

    European Journal of Surgical Oncology, Vol. 45, Núm. 1, pp. 46-51

2018

  1. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries

    The Lancet, Vol. 391, Núm. 10125, pp. 1023-1075

2017

  1. Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based study

    The Lancet Oncology, Vol. 18, Núm. 8, pp. 1022-1039

  2. Data quality in rare cancers registraton: The report of the RARECARE data quality study

    Tumori, Vol. 103, Núm. 1, pp. 22-32

  3. Erratum to “The histology of ovarian cancer: Worldwide distribution and implications for international survival comparisons (CONCORD-2)” [Gynecol. Oncol. 144 (2017) 405–413](S0090825816314974)(10.1016/j.ygyno.2016.10.019)

    Gynecologic Oncology

  4. Erratum to “Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2)” [Gynecol. Oncol. 144 (2017) 396–404](S009082581631575X)(10.1016/j.ygyno.2016.11.019)

    Gynecologic Oncology

  5. Geographical variability in survival of European children with central nervous system tumours

    European Journal of Cancer, Vol. 82, pp. 137-148

  6. Quality analysis of population-based information on cancer stage at diagnosis across Europe, with presentation of stage-specific cancer survival estimates: A EUROCARE-5 study

    European Journal of Cancer, Vol. 84, pp. 335-353

  7. Survival of 86,690 patients with thyroid cancer: A population-based study in 29 European countries from EUROCARE-5

    European Journal of Cancer, Vol. 77, pp. 140-152

  8. The histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2)

    Gynecologic Oncology, Vol. 144, Núm. 2, pp. 405-413

  9. Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2)

    Gynecologic Oncology, Vol. 144, Núm. 2, pp. 396-404

  10. Worldwide comparison of survival from childhood leukaemia for 1995–2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89 828 children from 198 registries in 53 countries

    The Lancet Haematology, Vol. 4, Núm. 5, pp. e202-e217